Paroxetine hydrochloride market is expected to rise at a considerable CAGR during the forecast period (2023-2029). Paroxetine is used to treat panic attacks, depression, OCD, anxiety disorders, and post-traumatic stress disorder. It works by assisting in the restoration of natural chemical equilibrium in the brain (serotonin). Paroxetine is a serotonin reuptake inhibitor with a narrow therapeutic range (SSRI). This medicine may enable you to regain your interest in daily activities by improving your mood, sleep, appetite, and energy. It enables to reduce panic episodes by reducing fear, worry, and undesirable thoughts. It may additionally, enable compulsions (such as hand washing, counting, and checking) that interfere with daily life. The major factor for the growth of the market is the increasing prevalence of anxiety and depression. According to the Anxiety and Depression Association of America (ADAA), Anxiety disorders are the most common mental illness that affects 40 million adults of age 18 and older or 18.1% of the population every year while panic disorder affects 6 million adults or 2.7% of the population in the US.
The Covid-19 has benefited the paroxetine hydrochloride market. Stress, worry, and sadness caused by COVID-19 affect mental health and contribute to anxiety, stress such as losing the job during Covid-19. People started taking anti-depression pills. These factors raised the demand for paroxetine hydrochloride hence rises the growth of the paroxetine Hydrochloride market globally.
The global paroxetine hydrochloride market is segmented based on type and application. Based on type, the market is sub-segmented into purity: 98%-99% and purity: above 99%. Based on application the market is sub-segmented into OCD treatment, anxiety treatment, others.
To Request a Sample of our Report on Paroxetine Hydrochloride Market: https://www.omrglobal.com/request-sample/paroxetine-hydrochloride-market
Paroxetine Hydrochloride Market Segmentation
By Type
- Purity: 98%-99%
- Purity: above 99%
By Application
- OCD Treatment
- Anxiety Treatment
- Others
A full Report of Paroxetine Hydrochloride Market is Available @ https://www.omrglobal.com/industry-reports/paroxetine-hydrochloride-market
Regional Analysis
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
Company Profiles
- Aurobindo Pharma Ltd.
- Cadila Healthcare Ltd.
- Dycine Pharmaceuticals Ltd.
- Enal Drugs Pvt. Ltd.
- Intra life (doxis laboratories)
- Jubilant Pharma Ltd.
- Lupin Ltd.
- Lannett Company, Inc.
- Medichem India Pvt. Ltd.
- Maiden Pharmaceuticals ltd.
- Noven Pharmaceuticals Inc.
- Psychotop (Solitaire Pharmacia Pvt. Ltd.)
- Quality Pharma Products Pvt. Ltd.
- Sandoz Pharmaceuticals (Novartis Group)
- Shreya Life Sciences Pvt. Ltd.
- Sciecure Pharma Inc.
- Teva Pharmaceutical Industries Ltd.
- Zhejiang Huahai Pharmaceutical Co. Ltd.
- Zhejiang Jian-Feng Pharmaceutical Co. Ltd.
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/paroxetine-hydrochloride-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
